Fingerprint
Dive into the research topics of 'Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies
Ruben A. Mesa*, Stacie Hudgens, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal P. McLornan, Mary F. McMullin, Jean-Jaques Kiladjian, Lynda Foltz, Uwe Platzbecker, M. Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Perkins, Michael F. Leahy, Samineh Deheshi, Rafe Donahue, Barbara J. Klencke
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
7
Citations
(Scopus)
9
Downloads
(Pure)